Wednesday, April 7, 2021 (Health Day News)-New research shows that doctors all over the world are looking at this situation: about one-third of COVID-19 patients continue to develop a few months after infection “Long distance” neurosis or psychosis.
Researchers report that these findings indicate a link between COVID-19 and a higher risk of later mental health and neurological diseases.
The new analysis of data from more than 236,000 COVID-19 survivors focuses on 14 neurological and psychiatric diseases. The study found that within six months after the new coronavirus infection, 34% of patients were diagnosed with such diseases.
Most commonly, these diseases range from anxiety disorders to substance abuse disorders, insomnia, cerebral hemorrhage, stroke and dementia (rarely).
For 13% of these patients, this is their first such diagnosis.
Jonathan Rogers of University College London wrote in an editorial: “Unfortunately, many of the diseases found in this study are often chronic or recurrent, so we can expect that the impact of COVID-19 may be accompanied by We have been for many years.” With new research.Both were posted on April 6th The Lancet Psychiatry.
An American expert who was not involved in the study agreed.
Dr. Andrew Rogove, medical director of stroke services at South Bank University Hospital, South Bay University in New York State, said: “There is a need to allocate services and resources for this kind of care.”
The new research was led by Paul Harrison of the University of Oxford in the United Kingdom. His team reviewed electronic health records to track the results of 236,379 COVID-19 patients, most of whom were from the United States.
Approximately one-third of people do experience some kind of neurological or mental health problem within six months of being infected by the coronavirus. The research team said that anxiety disorders (17%), mood disorders (14%), substance abuse disorders (7%) and insomnia (5%) are the most common diseases.
The overall incidence of neurological diseases is much lower. Among them, the incidence of cerebral hemorrhage is 0.6%, the incidence of ischemic stroke is 2.1%, and the incidence of dementia is 0.7%.
Nervous system diseases are more common in patients severely infected with COVID-19. For example, Harrison’s team reported that 7% of patients in intensive care had a stroke and nearly 2% of patients were diagnosed with dementia.